- Home
- CLEU vs ATRC Comparison
CLEU vs ATRC Comparison
Compare CLEU & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLEU
- ATRC
- Stock Information
- Founded
- CLEU 2011
- ATRC 2000
- Country
- CLEU China
- ATRC United States
- Employees
- CLEU N/A
- ATRC N/A
- Industry
- CLEU Other Consumer Services
- ATRC Medical/Dental Instruments
- Sector
- CLEU Real Estate
- ATRC Health Care
- Exchange
- CLEU Nasdaq
- ATRC Nasdaq
- Market Cap
- CLEU 1.0B
- ATRC 1.1B
- IPO Year
- CLEU 2020
- ATRC 2005
- Fundamental
- Price
- CLEU $5.01
- ATRC $38.47
- Analyst Decision
- CLEU
- ATRC Strong Buy
- Analyst Count
- CLEU 0
- ATRC 9
- Target Price
- CLEU N/A
- ATRC $41.78
- AVG Volume (30 Days)
- CLEU 756.5K
- ATRC 535.9K
- Earning Date
- CLEU 10-11-2024
- ATRC 02-13-2025
- Dividend Yield
- CLEU N/A
- ATRC N/A
- EPS Growth
- CLEU N/A
- ATRC N/A
- EPS
- CLEU N/A
- ATRC N/A
- Revenue
- CLEU $2,413,409.00
- ATRC $447,573,000.00
- Revenue This Year
- CLEU N/A
- ATRC $17.75
- Revenue Next Year
- CLEU N/A
- ATRC $13.44
- P/E Ratio
- CLEU N/A
- ATRC N/A
- Revenue Growth
- CLEU N/A
- ATRC 17.56
- 52 Week Low
- CLEU $0.12
- ATRC $18.94
- 52 Week High
- CLEU $5.53
- ATRC $39.12
- Technical
- Relative Strength Index (RSI)
- CLEU 75.27
- ATRC 70.10
- Support Level
- CLEU $3.28
- ATRC $31.00
- Resistance Level
- CLEU $5.53
- ATRC $34.11
- Average True Range (ATR)
- CLEU 0.83
- ATRC 1.76
- MACD
- CLEU 0.10
- ATRC 0.86
- Stochastic Oscillator
- CLEU 79.37
- ATRC 93.03
About CLEU China Liberal Education Holdings Limited
China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.